| Name | Title | Contact Details |
|---|
iRise is dedicated to bridging the communication gap between customers, business and IT by dramatically improving the process of defining business applications.
Nuance is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance`s proven applications.
MediMobile is Mobile Charge Capture software, the leading technology provider of practice and revenue cycle management in healthcare.
Together, we can win the war on cybercrime. We believe the Internet should be a safe place to work. Free from cybercrime, cyberwar, ransomware, theft of trade secrets, harvesting corporate knowledge, insider threats, and IoT extraction of data. INTRUSION has subject matter experts in cybersecurity, big data engineering, process flow technology, and machine learning. We leverage decades of experience and dynamic technology to design hardware and software solutions that offer your organization the best possible cyber defense. Join us and win the war on cybercrime.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.